Study Information

Purpose of Study

The purpose of this study is to determine how insulin levels in the blood affect the way the kidneys eliminate phosphate into the urine in people with type 2 diabetes that have either normal or moderately reduced kidney function.


Queen’s-KRU (Kidney Research Unit)


Kingston Health Sciences Centre – Kingston General Hospital site
76 Stuart Street
Kingston, Ontario
K7L 2V7

Compensation Info

Compensation is $50 for 1 visit.

Who is Conducting the Study?

Co-Principal Investigators: Dr. Rachel Holden and Dr. Christine White, Queen’s University/Kingston Health Science Centre – Kingston General Hospital site.

Co-investigators: Aysha Draves, M.Sc. (Candidate), Queen’s University, Dr. Robyn Houlden and Dr. Jocelyn Garland, Queen’s University/Kingston Health Sciences Centre – Kingston General Hospital site, and Dr. Michael A. Adams, Biomedical and Molecular Sciences, Queen’s University.

Main Contact: Corinne Babiolakis

Benefits to Participant

You will not benefit directly from this study; however results from this study may improve the understanding of how insulin affects phosphate excretion and may benefit people in the future.

Inclusion/Exclusion Criteria

  1. Adults aged 40 and 80 who have non-insulin dependent type 2 diabetes with or without reduced kidney function
  1. Known allergy to contrast
  2. Known allergy to shellfish
  3. Insulin use

What the Participant Will Be Asked To Do

If you decide to take part in this study, you will be asked to visit the hospital for one visit. The test will take approximately 5 hours to complete. The visit includes:

  1. Blood samples
  2. Urine samples
  3. Consumption of an oral phosphate drink (1 cup of water that contains a total of 500 mg of phosphate)
  4. Questions regarding your medication and supplement use

Interested in Participating?

Please email the researcher using the contact researcher button below to set up your appointment.

Contact Researcher Back to Browse

Share this study with someone you know!